BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34367239)

  • 1. Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer.
    Zheng J; Guo J; Zhang H; Cao B; Xu G; Zhang Z; Tong J
    Front Genet; 2021; 12():672674. PubMed ID: 34367239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Potential Immune-Related Long Non-coding RNA Prognostic Signature for Ovarian Cancer.
    Pan X; Bi F
    Front Genet; 2021; 12():694009. PubMed ID: 34367253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
    Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
    Front Oncol; 2021; 11():640150. PubMed ID: 33869028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
    Zheng J; Guo J; Cao B; Zhou Y; Tong J
    Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of competitive endogenous RNAs networks reveals potential prognostic biomarkers associated with epithelial ovarian cancer.
    Wu W; Gao C; Chen L; Zhang D; Guo S
    Oncol Lett; 2021 Dec; 22(6):843. PubMed ID: 34777587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analyses of mitophagy-related genes and mitophagy-related lncRNAs for patients with ovarian cancer.
    Zheng J; Jiang S; Lin X; Wang H; Liu L; Cai X; Sun Y
    BMC Womens Health; 2024 Jan; 24(1):37. PubMed ID: 38218807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of LncRNA Prognostic Markers for Ovarian Cancer by Integration of Co-expression and CeRNA Network.
    Liang H; Bai Y; Wang H; Yang X
    Front Genet; 2020; 11():566497. PubMed ID: 33664764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Combined Long Noncoding RNA Signature as a Candidate Prognostic Biomarker for Ovarian Cancer.
    Li H; Wang S; Yao Q; Liu Y; Yang J; Xu L; Yang G
    Front Oncol; 2021; 11():624240. PubMed ID: 34123783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
    Liu Z; Wang X; Yang G; Zhong C; Zhang R; Ye J; Zhong Y; Hu J; Ozal B; Zhao S
    J Cell Biochem; 2020 Jul; 121(7):3502-3515. PubMed ID: 32277520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
    Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
    Front Oncol; 2020; 10():780. PubMed ID: 32587825
    [No Abstract]   [Full Text] [Related]  

  • 12. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Analysis of a Risk Score System Predicting Prognosis and a ceRNA Network for Differentially Expressed lncRNAs in Multiple Myeloma.
    Zhou S; Fang J; Sun Y; Li H
    Front Genet; 2020; 11():934. PubMed ID: 33193574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Novel Immune-Related lncRNA CTD-2288O8.1 Regulating Cisplatin Resistance in Ovarian Cancer Based on Integrated Analysis.
    Liu T; Shen J; He Q; Xu S
    Front Genet; 2022; 13():814291. PubMed ID: 35237300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of a 9-gene signature for the prognosis of ovarian cancer by integrated bioinformatical analysis.
    Chen S; Yang M; Yang H; Tang Q; Gu C; Wei W
    Ann Transl Med; 2022 Oct; 10(19):1059. PubMed ID: 36330389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
    Qi M; Yu B; Yu H; Li F
    Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis-Related Long Noncoding RNAs as Prognostic Biomarkers for Ovarian Cancer.
    Wang K; Mei S; Cai M; Zhai D; Zhang D; Yu J; Ni Z; Yu C
    Front Oncol; 2022; 12():888699. PubMed ID: 35756659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
    Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer.
    Liu S; Cao Q; An G; Yan B; Lei L
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.